Spirogen Sarl
Lausanne, CH
Spirogen Sarl Patent applications | ||
Patent application number | Title | Published |
---|---|---|
20160106861 | AXL ANTIBODY-DRUG CONJUGATE AND ITS USE FOR THE TREATMENT OF CANCER - The present invention relates to an antibody-drug conjugate capable of binding to the protein Axl. From one aspect, the invention relates to an antibody-drug conjugate comprising an antibody capable of binding to Axl, said antibody being conjugated to at least one drug which is a pyrrolobenzodiazepme dimer (PBD dimer) drug. The invention also comprises method of treatment and the use of said antibody-drug conjugate for the treatment of cancer. | 04-21-2016 |
20160015828 | NOVEL ANTIBODY CONJUGATES AND USES THEREOF - Provided are novel antibody drug conjugates (ADCs), and methods of using such ADCs to treat proliferative disorders. | 01-21-2016 |
20140275522 | SYNTHESIS METHOD AND INTERMEDIATES USEFUL IN THE PREPARATION OF PYRROLOBENZODIAZEPINES - A compound of formula I wherein: R | 09-18-2014 |
20140274907 | PYRROLOBENZODIAZEPINES - A compound with the formula (I), wherein: R | 09-18-2014 |
20140234346 | PYRROLOBENZODIAZEPINES - A compound with the formula I: wherein: R | 08-21-2014 |
20140142090 | UNSYMMETRICAL PYRROLOBENZODIAZEPINE-DIMERS FOR TREATMENT OF PROLIFERATIVE DISEASES - The present invention is directed to novel pyrrolobenzodiazepine dimers and methods of using the dimers in the treatment of proliferative diseases. | 05-22-2014 |
20140127239 | PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF - A compound which is either A: | 05-08-2014 |
20140120118 | PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF - A compound which is selected from A: | 05-01-2014 |
20140066435 | PYRROLOBENZODIAZEPINES USED TO TREAT PROLIFERATIVE DISEASES - Pyrrolobenzodiazepine dimers having a C2-C3 double bond and an aryl group at the C2 position on one monomer unit, and a C2-C3 double bond and either a conjugated double or triple bond at the C2 position or an alkyl group at the C2 position on the other monomer unit, and conjugates of these compounds. | 03-06-2014 |
20140030279 | ANTI-CD22 ANTIBODIES AND IMMUNOCONJUGATES - The invention provides anti-CD22 antibodies and immunoconjugates and methods of using the same. | 01-30-2014 |